Involvement of N-methyl-D-aspartate receptors in plasticity induced by paired corticospinal-motoneuronal stimulation in humans

被引:18
|
作者
Donges, Siobhan C. [1 ,2 ]
D'Amico, Jessica M. [1 ]
Butler, Jane E. [1 ,2 ]
Taylor, Janet L. [1 ,2 ,3 ]
机构
[1] Neurosci Res Australia, Barker St, Randwick, NSW 2031, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Edith Cowan Univ, Joondalup, WA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
dextromethorphan; plasticity; transcranial magnetic stimulation; TIMING-DEPENDENT PLASTICITY; HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM DEPRESSION; HUMAN SPINAL-CORD; ASSOCIATIVE STIMULATION; ELECTRICAL-STIMULATION; SYNAPTIC PLASTICITY; NMDA RECEPTORS; NONINVASIVE STIMULATION;
D O I
10.1152/jn.00457.2017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Plasticity can be induced at human corticospinal-motoneuronal synapses by delivery of repeated, paired stimuli to corticospinal axons and motoneurons in a technique called paired corticospinal-motoneuronal stimulation (PCMS). To date, the mechanisms of the induced plasticity are unknown. To determine whether PCMS-induced plasticity is dependent on N-methyl-D-aspartate receptors (NMDARs), the effect of the noncompetitive NMDAR antagonist dextromethorphan on PCMS-induced facilitation was assessed in a 2-day, double-blind, placebo-controlled experiment. PCMS consisted of 100 pairs of stimuli, delivered at an interstimulus interval that produces facilitation at corticospinal-motoneuronal synapses that excite biceps brachii motoneurons. Transcranial magnetic stimulation elicited corticospinal volleys, which were timed to arrive at corticospinal-motoneuronal synapses just before antidromic potentials elicited in motoneurons with electrical brachial plexus stimulation. To measure changes in the corticospinal pathway at a spinal level, biceps responses to cervicomedullary stimulation (cervicomedullary motor evoked potentials, CMEPs) were measured before and for 30 min after PCMS. Individuals who displayed a >= 10% increase in CMEP size after PCMS on screening were eligible to take part in the 2-day experiment. After PCMS, there was a significant difference in CMEP area between placebo and dextromethorphan days (P = 0.014). On the placebo day PCMS increased average CMEP areas to 127 +/- 46% of baseline, whereas on the dextromethorphan day CMEP area was decreased to 86 +/- 33% of baseline (mean +/- SD; placebo: n = 11, dextromethorphan: n = 10). Therefore, dextromethorphan suppressed the facilitation of CMEPs after PCMS. This indicates that plasticity induced at synapses in the human spinal cord by PCMS may be dependent on NMDARs. NEW & NOTEWORTHY Paired corticospinal-motoneuronal stimulation can strengthen the synaptic connections between corticospinal axons and motoneurons at a spinal level in humans. The mechanism of the induced plasticity is unknown. In our 2-day, double-blind, placebo-controlled study we show that the N-methyl-D-aspartate receptor (NMDAR) antagonist dextromethorphan suppressed plasticity induced by paired corticospinal-motoneuronal stimulation, suggesting that an NMDAR-dependent mechanism is involved.
引用
收藏
页码:652 / 661
页数:10
相关论文
共 50 条
  • [31] Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression
    Casado, M
    Isope, P
    Ascher, P
    NEURON, 2002, 33 (01) : 123 - 130
  • [32] DESENSITIZATION OF N-METHYL-D-ASPARTATE RECEPTORS - A PROBLEM OF INTERPRETATION
    COLQUHOUN, D
    HAWKES, AG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) : 10327 - 10329
  • [33] N-methyl-D-aspartate receptors in opioid dependence and withdrawal
    Rockhold, R
    Zhu, H
    Liu, NS
    Ho, IK
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 389 - 392
  • [34] Opiate physical dependence and N-methyl-D-aspartate receptors
    Noda, Y
    Nabeshima, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) : 121 - 128
  • [35] THE RELATIONSHIP OF N-METHYL-D-ASPARTATE RECEPTORS AND MAJOR DEPRESSION
    Zhang, H. S.
    Shi, L. J.
    Sun, L. X.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 29 - 29
  • [36] N-methyl-D-aspartate receptors in hyperammonaemia and hepatic encephalopathy
    Erceg, S.
    Rodrigo, R.
    Monfort, P.
    Llansalo, M.
    Montoliu, C.
    Sanchez-Perez, A. M.
    Cauli, O.
    Piedrafita, B.
    Felipo, V.
    HEPATIC ENCEPHALOPATHY AND NITROGEN METABOLISM, 2006, : 183 - 193
  • [37] Localization and functions of neurokinin and N-methyl-D-aspartate receptors
    Adam, B
    Liebregts, T
    Gerken, G
    Holtmann, G
    GASTROINTESTINAL INFLAMMATION AND DISTURBED GUT FUNCTION: THE CHALLENGE OF NEW CONCEPTS, 2003, 130 : 253 - 259
  • [38] N-METHYL-D-ASPARTATE RECEPTORS AND NITRIC-OXIDE
    BOCKAERT, J
    OLIVIER, M
    MANZONI, O
    LAFONCAZAL, M
    MARIN, P
    FAGNI, L
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S52 - S52
  • [39] Protein quality control of N-methyl-D-aspartate receptors
    Benske, Taylor M.
    Mu, Ting-Wei
    Wang, Ya-Juan
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [40] Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
    Chen, Shuang
    Xu, Da
    Fan, Liu
    Fang, Zhi
    Wang, Xiufeng
    Li, Man
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 14